Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 2
1(14.3%)
7Total
N/A(6)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07361640Not ApplicableRecruiting

DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes

Role: collaborator

NCT04837989Not ApplicableTerminated

Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes

Role: collaborator

NCT01710774Not ApplicableUnknown

Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers

Role: collaborator

NCT03870724Completed

Women and Risk of Type 2 Diabetes

Role: collaborator

NCT04662866Phase 2Unknown

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose

Role: collaborator

NCT02569684Not ApplicableCompleted

Effects of Prebiotics on GLP-1 in Type 2 Diabetes

Role: collaborator

NCT00824148Not ApplicableCompleted

Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus

Role: collaborator

NCT00829569Not ApplicableCompleted

n-3 Fatty Acid Infusion and Type 2 Diabetes

Role: collaborator

All 8 trials loaded